[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Thammasat University Hospital\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":107},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,49,77],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":28,"overallStatus":36,"whyStopped":4,"lastUpdateSubmitDate":37,"lastUpdatePostDateStruct":38,"startDateStruct":41,"completionDateStruct":43,"leadSponsor":45,"locationsCount":48},"100586096","impact-of-muscle-training-device-on-non-severe-osa-100586096",false,"NCT06910930","Impact of Muscle Training Device on Non-Severe OSA","Impact of Muscle Training Device on Non-Severe OSA: A Randomized Controlled Study","Inclusion Criteria:\n\n* Patients diagnosed with mild to moderate obstructive sleep apnea.\n* Age 18 years or older.\n* Patients voluntarily consent to provide information for research purposes.\n\nExclusion Criteria:\n\n* Patients with an average apnea-hypopnea index (AHI) of \\\u003C4 or \\>29 events per hour after repeated diagnosis using a home sleep apnea test.\n* Patients who refused to cease using CPAP during the study process\n* Patients with a history of chronic lung disease.\n* Elderly patients with neurological conditions that impair cognitive function, such as dementia, stroke, or psychiatric disorders.\n* Patients taking medications that may affect muscle function within 3 months before the start of the study.\n* Patients with hypothyroidism or other conditions that may affect muscle function.\n* Patients who consume alcohol at a moderate level or higher","ALL","18 Years",{"count":19,"type":20},76,"ESTIMATED","INTERVENTIONAL",[23],"NA","The goal of this clinical trial is to test for the efficacy of the newly invented device #DidgeriTU with non-severe obstructive sleep apnea. The main question it aims to answer is:\n\n• Can DidgeriTU reduce apnea events in patients with non-severe obstructive sleep apnea? Researchers will compare DidgeriTU with a sham device to see how the apnea event has changed.\n\nParticipants will:\n\n* Use DidgeriTU or sham device for 3 month\n* Do an online questionnaire once a month during the study\n* Home sleep test, lung function test, and tongue strength test at the start and end of the study",[26,27],"OSA","Obstructive Sleep Apnea",[29,30,31,32,33,34,35],"Device","EMST","Powerbreathe","didgeridoo","didgeriTU","Expiratory muscle exercise","reverse CPAP","RECRUITING","2026-01-17",{"date":39,"type":40},"2026-01-21","ACTUAL",{"date":42,"type":40},"2025-05-01",{"date":44,"type":20},"2026-03-15",{"name":46,"class":47},"Thammasat University Hospital","OTHER",1,{"id":50,"slug":51,"hasResults":11,"nctId":52,"briefTitle":53,"officialTitle":54,"acronym":55,"eligibilityCriteria":56,"healthyVolunteers":57,"sex":16,"minAge":58,"maxAge":4,"enrollmentInfo":59,"targetDuration":4,"studyType":21,"phases":61,"briefSummary":62,"conditions":63,"keywords":65,"overallStatus":36,"whyStopped":4,"lastUpdateSubmitDate":68,"lastUpdatePostDateStruct":69,"startDateStruct":71,"completionDateStruct":73,"leadSponsor":75,"locationsCount":76},"100588565","evaluation-of-ioband-coverage-waterproof-dressing-versus-isolated-waterproof-dressing-after-primary-total-knee-arthroplasty-100588565","NCT06943053","Evaluation of Ioband Coverage Waterproof Dressing Versus Isolated Waterproof Dressing After Primary Total Knee Arthroplasty","Does Ioband Coverage Waterproof Dressing Provide Better Outcome Than Isolate Waterproof Dressing After Primary Total Knee Arthroplasty? A Prospective Randomized Controlled Trial","Wound coverage","Inclusion Criteria:\n\n* Primary unilateral TKA\n* Age 55-80 yrs\n\nExclusion Criteria:\n\n* Chronic Skin disease such as Psoriasis\n* Chronic steroid use\n* Allergy to skin adhesive, Cover wound\n* Robotic TKA\n* Iodine allergy\n* Not follow protocol",true,"55 Years",{"count":60,"type":20},96,[23],"Title: Evaluation of Ioband® Coverage Waterproof Dressing in Post-Operative Total Knee Arthroplasty (TKA)\n\nGoal: To evaluate the effectiveness of Ioband® coverage waterproof dressing compared to standard waterproof dressing in reducing dressing change frequency and peel-off degree post-op TKA.\n\nMain Research Questions:\n\n1. Does Ioband® coverage waterproof dressing significantly decrease the degree of peel-off compared to standard waterproof dressing?\n2. Does Ioband® coverage reduce the number of wound dressing changes required post-operatively?\n3. Does Ioband® coverage improve overall patient satisfaction compared to standard waterproof dressing?\n\nParticipants:\n\nParticipants will include patients who have undergone total knee arthroplasty (TKA).\n\nMain Tasks and Interventions:\n\n1. Randomization: Participants will be randomly assigned to receive either the Ioband® coverage waterproof dressing or the standard waterproof dressing.\n2. Application of Dressings: Participants will have the assigned dressing applied to their surgical site post-operatively.\n3. Assessment of Peel-Off Degree: Participants will undergo assessments to evaluate the degree of peel-off of the dressing over a specified time.\n4. Wound Dressing Changes: Participants will have their dressing changed as per routine care protocols, with documentation of the number of changes.\n5. Patient Satisfaction Survey: Participants will complete a satisfaction survey to assess their experiences with the dressing and overall comfort.\n\nConclusion: The trial aims to provide insights into the benefits of Ioband® coverage waterproof dressing in improving post-operative care for TKA patients, focusing on key outcomes related to dressing performance and patient satisfaction.",[64],"Postoperative Wound Care After TKA",[66,67],"total knee arthroplasty","Ioband® coverage waterproof dressing","2025-04-17",{"date":70,"type":40},"2025-04-24",{"date":72,"type":40},"2025-04-06",{"date":74,"type":20},"2026-04-16",{"name":46,"class":47},2,{"id":78,"slug":79,"hasResults":11,"nctId":80,"briefTitle":81,"officialTitle":82,"acronym":4,"eligibilityCriteria":83,"healthyVolunteers":11,"sex":16,"minAge":84,"maxAge":85,"enrollmentInfo":86,"targetDuration":4,"studyType":21,"phases":88,"briefSummary":89,"conditions":90,"keywords":94,"overallStatus":36,"whyStopped":4,"lastUpdateSubmitDate":99,"lastUpdatePostDateStruct":100,"startDateStruct":102,"completionDateStruct":104,"leadSponsor":106,"locationsCount":48},"100541300","comparing-efficiency-of-mirogabalin-and-pregabalin-in-primary-tka-100541300","NCT06328062","Comparing Efficiency of Mirogabalin and Pregabalin in Primary TKA","Comparison Efficacy of Mirogabalin and Pregabalin in Total Knee Arthroplasty. a Randomized Controlled Trial","Inclusion Criteria:\n\n1. Age 50-85 years old\n2. Unilateral primary osteoarthritis undergoing primary TKA\n3. ASA I-III\n\nExclusion Criteria:\n\n1. GFR \\<60\n2. Allergy to drug in this study\n3. Cannot underwent spinal anesthesia and adductor canal block\n4. Taking gabapentinoid within 3 months before surgery\n5. History of previous knee surgery\n6. Severe liver disease","50 Years","85 Years",{"count":87,"type":20},80,[23],"The goal of this RCT is to compare efficacy between mirogabalin and pregabalin in pain reducing after unilateral primary total knee arthroplasty.\n\nThe main question\\[s\\] it aims to answer are:\n\n• Does mirogabalin have better pain reduction than pregabalin after unilateral primary total knee arthroplasty.\n\nParticipants will randomized to mirogabalin or pregabalin group and will take the drug for 6 weeks after TKA. Researchers will compare to pregabalin group to see pain and functional outcomes after TKA.",[91,92,93],"Pain Postoperative","Osteoarthritis","Total Knee Arthroplasty",[95,96,97,98],"mirogabalin","pregabalin","pain postoperative","TKA","2025-04-05",{"date":101,"type":40},"2025-04-09",{"date":103,"type":40},"2024-04-01",{"date":105,"type":20},"2025-05-31",{"name":46,"class":47},""]